Needham Investment Management LLC Avrobio, Inc. Transaction History

Needham Investment Management LLC

  • $1.23 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
$0.76 - $1.82 $4,170 - $9,986
5,487 Added 22.38%
30,000 $30,000
Q2 2022

Aug 12, 2022
BUY
$0.75 - $1.33 $10,500 - $18,620
14,000 Added 133.17%
24,513 $23,000
Q4 2021

Feb 14, 2022
SELL
$3.45 - $6.05 $1,680 - $2,946
-487 Reduced 4.43%
10,513 $40,000
Q3 2021

Nov 15, 2021
BUY
$5.53 - $9.28 $60,830 - $102,080
11,000 New
11,000 $61,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Needham Investment Management LLC Portfolio

Follow Needham Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Needham Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Needham Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email